CHI3L1 and myeloid sarcoma: Elevated CSF CHI3L1 levels in CIS patients have been validated as a prognostic marker for conversion from CIS or optic neuritis to clinically-defined MS [75,76], and they correlate with a shorter time for conversion from CIS to MS, a more rapid accrual of disability and an increased likelihood of cognitive impairment [26].